Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia. - Wikidata - wikimedia - TriplyDB

Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.

Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q41625025

about

Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells.Role of Distinct Natural Killer Cell Subsets in Anticancer Response.NK Cell Exhaustion.Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.Control of NK Cell Activation by Immune Checkpoint Molecules.Monoclonal Antibody Therapies for Hematological Malignancies: Not Just Lineage-Specific Targets.NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation.NKG2A Expression Is Not per se Detrimental for the Anti-Multiple Myeloma Activity of Activated Natural Killer Cells in an In Vitro System Mimicking the Tumor Microenvironment.Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells

P2860

Q39110347-6CEB1D84-441B-474A-B337-EFDF4937BFBD Q39210022-AB2D8AB3-DB24-4B3A-B6A6-CB2C0FDF57D0 Q39431541-FE3E3B2F-7B76-4D65-B047-D461201C6126 Q42660142-D3665BED-FFEE-48D8-BA41-E309367DA2AC Q47128718-749E019C-800E-4299-97BC-E0B358E48966 Q49539698-EACE8943-BC1D-41B4-A63B-5D21687E41F6 Q50502690-BAD9F0B1-FC87-4805-B633-220BD382C313 Q52560280-2326050F-B482-46CA-9D53-B4E1ECE463E3 Q55514845-CABA2C3F-12F1-401D-BFF3-284D09B6CA7B Q56889003-CFE31439-5089-457D-8CB7-AD63FBE592F0

P2860

Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q41625025

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Therapeutic CD94/NKG2A blockad ...... chronic lymphocytic leukemia.

@en

type

label

Therapeutic CD94/NKG2A blockad ...... chronic lymphocytic leukemia.

@en

prefLabel

Therapeutic CD94/NKG2A blockad ...... chronic lymphocytic leukemia.

@en

P1433

Q41625025-035DDF89-4498-442D-BBF2-1B7692D1B766

P1476

Q41625025-7BF00825-36E9-43F5-A5C4-382720929388

P2093

Q41625025-044C184A-B98E-4791-A119-6396FC632DB2

Q41625025-09B6FEA1-0F70-43A3-BA45-B89C6272E7A4

Q41625025-1A6F3319-7094-4982-B967-46BA4EE4D6D2

Q41625025-3C36304D-C675-46E4-89FC-759A527CB54F

Q41625025-511DF08E-C317-413C-BB3B-91E8CF627E00

Q41625025-A37C941F-01AC-46E2-BB6F-4AB1ADF03CAC

Q41625025-C04756C7-A0AF-4454-AFCB-6F47303F8CE2

Q41625025-DCCD5B8A-6DA3-4C51-B8F0-5200EC23DE5F

Q41625025-E26A53D6-1076-4A20-98A3-2699B422D1F3

P2860

Q41625025-0BD7EBBD-1506-44E8-86B3-A2485703C9FC

Q41625025-16E7AB49-3C12-462A-9F86-2AF00B51F1CF

Q41625025-203CD46D-AB27-465A-8D12-F008756F6425

Q41625025-2A7CB999-8BC5-49C5-A9A6-8A52EE5B6055

Q41625025-4875BA10-C5C0-40E3-B516-AE0C7DDFE6FD

Q41625025-593D08EE-7663-4C38-987D-ABFAE4BF44AF

Q41625025-5AAA5203-9159-47DA-A5CA-1EEB47BAAA73

Q41625025-5CC94D08-6EE2-4DED-AB43-44E0F7EE5651

Q41625025-5DB50CF0-B946-4ECB-8513-408F3AF9A997

Q41625025-6FF8BA00-D2C5-48D9-BB4B-633D96A1D43E

P304

Q41625025-29CAE621-D1EF-406D-8D08-6BB7E787A073

P31

Q41625025-4317F0BA-0489-4015-8EC6-58F124752D8E

P356

Q41625025-1F450F65-3159-4B3E-A349-BFE4401030C2

P433

Q41625025-C678E25C-AEAE-4DE0-88A5-D2ECCC14C4D2

P478

Q41625025-700E7730-8C5C-4F9A-82EB-7F882DC8A891

P50

Q41625025-AF7AB6AC-501C-4A3B-B1B5-46FFCBAEA19E

P577

Q41625025-E8B00EF6-7303-4A98-B097-4867C2CF8684

P698

Q41625025-65D77DF4-C79B-42A2-932C-BBA2674CB94C

P921

Q41625025-E4088442-8ED5-4A51-BFBD-830F397E36B2

P932

Q41625025-C012A670-723E-45D0-937B-56B124F73C38

P356

2162402X.2016.1226720

P1433

P1476

Therapeutic CD94/NKG2A blockad ...... chronic lymphocytic leukemia.

@en

P2093

Carolyn Cheney

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Timmerman

http://www.w3.org/2001/XMLSchema#string

Emily M McWilliams

http://www.w3.org/2001/XMLSchema#string

Ethan J Strattan

http://www.w3.org/2001/XMLSchema#string

Faraz Fiazuddin

http://www.w3.org/2001/XMLSchema#string

Farrukh T Awan

http://www.w3.org/2001/XMLSchema#string

Jennifer M Mele

http://www.w3.org/2001/XMLSchema#string

Natarajan Muthusamy

http://www.w3.org/2001/XMLSchema#string

Xiaokui Mo

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases

New strategies in chronic lymphocytic leukemia: shifting treatment paradigms

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

Cancer statistics, 2016

NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect.

The clinical application of monoclonal antibodies in chronic lymphocytic leukemia.

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

MHC class Ib molecules bridge innate and acquired immunity.

Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.

P304

e1226720

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2016.1226720

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27853650

http://www.w3.org/2001/XMLSchema#string

P921

P932

5087289

http://www.w3.org/2001/XMLSchema#string